Seller record · Telehealth service

Vital Edge

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S3, pharmacy identification: The answers say medication comes from licensed partner pharmacies, and no pharmacy is named on the home page, the contact page or the privacy policy. The terms page does not load. 3 more criteria also fail; see the table below.

At a glance

Vital EdgeTelehealth service

4/8criteria passed

Price: Compounded semaglutide $350 a month, compounded tirzepatide $450
Sells: compounded semaglutide, compounded tirzepatide, and 14 more
FDA letters: None on file

Visit Vital Edge See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A Chattanooga, Tennessee weight loss service with virtual visits selling compounded and brand-name semaglutide and tirzepatide, oral versions of both, sermorelin, NAD+, glutathione, GHK-Cu, PT-141 and men's health medication at flat monthly fees. It calls its GLP-1 medications FDA-approved, names no pharmacy and prints no street address.

Operating entity No legal entity name appears in the footer, on the contact page or in the privacy policy, and the terms of service link opens a page-not-found screen. The only name printed is the brand.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Vital Edge's website
S2	Prescription gating	PASS	Vital Edge's get started page
S3	Pharmacy identification	FAIL	Vital Edge's website; Vital Edge's privacy policy; Vital Edge's terms
S4	Compounding disclosure	FAIL	Vital Edge's website
S5	Analytical documentation	FAIL	Vital Edge's website
S6	Business address	FAIL	Vital Edge's contact page; Vital Edge's website; Vital Edge's terms
S7	Price disclosure	PASS	Vital Edge's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAfter the online intake the buyer is matched with a licensed physician who reviews the health history and prescribes a treatment plan only if appropriate.Source: Vital Edge's website.

S2PASSThe start page opens an intake whose first screen asks for basic details including current weight and height, with medical history before checkout. The page says the card is saved but charged only if a clinician approves the prescription.Source: Vital Edge's get started page.

S3FAILThe answers say medication comes from licensed partner pharmacies, and no pharmacy is named on the home page, the contact page or the privacy policy. The terms page does not load.Source: Vital Edge's website; Vital Edge's privacy policy; Vital Edge's terms.

S4FAILThe home page calls its GLP-1 medications FDA-approved, including semaglutide and tirzepatide, beside compounded semaglutide, tirzepatide and oral cards, and no page says a compounded drug is not FDA-approved.Source: Vital Edge's website.

S5FAILThe peptide cards describe the products as quality-tested, and no certificate of analysis or lot document is published.Source: Vital Edge's website.

S6FAILNo street address is printed. The contact page and the footer give only Chattanooga, Tennessee, and the terms page does not load.Source: Vital Edge's contact page; Vital Edge's website; Vital Edge's terms.

S7PASSCompounded semaglutide at $350 a month or $899 for 3 months, compounded tirzepatide at $450 a month or $1,199 for 3 months, oral semaglutide at $199 and oral tirzepatide at $269 a month, and brand Ozempic at $705, Mounjaro at $835, Wegovy at $990 and Rybelsus at $645 a month. Sermorelin at $200, NAD+ at $250, glutathione at $180, and GHK-Cu and PT-141 at $249 a month. The cost answer says pricing depends on the medication and dose prescribed, and the consult alone costs $80 if nothing is prescribed.Source: Vital Edge's website.

S8PASSNo FDA warning letter names Vital Edge or Your Vital Edge, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded oral semaglutide, compounded oral tirzepatide, Ozempic, Mounjaro, Wegovy, Rybelsus, lipotropic injection, sermorelin acetate, NAD+, glutathione injection, GHK-Cu, PT-141, testosterone replacement injection, tadalafil and sildenafil strips and tablets.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141 Who sells GHK-Cu

Visit Vital Edge

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.